consequences of glp 1 Physiologic effects GLP-1 (adapted from Granata et al. [11]) Glucagon-like Receptor-1 agonists for obesity:

doi: 10.1111/pcn.13323

En la DM2 existen alteraciones en el manejo renal de la glucosa que contribuyen a la hiperglicemia9,102

[9] To be able to confirm possible cardiovascular benefits of DPP-4 inhibitors requires large, double-blind, randomized trials with formal adjudication of cardiovascular end points

When you understand how it works, it becomes a lot clearer why a GLP-1 booster supplement can make such a noticeable difference

Cardiovasc Endocrinol Metabol

New GLP-1 drugs supplement your natural production, to treat Type 2 diabetes and lower risks of related complications such as heart disease and kidney damage